GEOGRAPHIC ATROPHY
Clinical trials for GEOGRAPHIC ATROPHY explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for dry AMD: drug aims to slow blind spot growth
Disease control CompletedThis study tested an experimental drug called ALK-001 in people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. About 200 participants received the drug and 100 received a placebo. The main goal was to see if ALK-001 coul…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2, PHASE3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 04:54 UTC
-
Blood-Derived injection shows promise for dry AMD
Disease control CompletedThis study tested whether injecting a concentrated form of the patient's own blood, called platelet-rich plasma (PRP), into the eye could slow the progression of advanced dry age-related macular degeneration (AMD). Fourteen people with dry AMD in both eyes received three PRP inje…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: NA • Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Disease control
Last updated May 26, 2026 04:48 UTC
-
Gene therapy shows promise in slowing vision loss from 'Dry' macular degeneration
Disease control CompletedThis study tested a new gene therapy, JNJ-81201887, in 305 people with geographic atrophy (advanced dry age-related macular degeneration). The goal was to see if a single injection into the eye could slow the growth of blind spots compared to a sham procedure. The therapy aims to…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 04:46 UTC
-
Eye drug safety check for advanced macular degeneration patients
Disease control CompletedThis study checks the long-term safety of an eye injection called avacincaptad pegol for people with geographic atrophy, a form of advanced age-related macular degeneration. It includes 278 adults aged 50 and older who completed a previous study of the same drug. The main goal is…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug shows promise in slowing blindness from dry AMD
Disease control CompletedThis study tested an eye injection called Zimura (avacincaptad pegol) in 448 people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes permanent vision loss. The goal was to see if the drug could slow the growth of damaged areas in the re…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE3 • Sponsor: IVERIC bio, Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Eye scans reveal clues to vision loss in dry AMD
Knowledge-focused CompletedThis study looked at 60 people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes permanent vision loss. Researchers reviewed past eye exams and scans to see how vision loss relates to changes in the retina. No new treatments were tested…
Matched conditions: GEOGRAPHIC ATROPHY
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated May 26, 2026 04:33 UTC